Luotea Oyj
6.3.2026 14:15:00 CET | Globenewswire | Press release
Luotea PLC - Managers' Transactions: Antti Niitynpää
Luotea PLC - Managers' Transactions: Antti Niitynpää
Luotea PLC
Stock exchange release
6 March 2026 at 3:15 pm
Luotea Oyj - Managers' Transactions: Antti Niitynpää
____________________________________________
Person subject to the notification requirement
Name: Antti Niitynpää
Position: Chief Executive Officer
Issuer: Luotea Oyj
LEI: 743700Z9Z54VGHZA0028
Notification type: INITIAL NOTIFICATION
Reference number: 144836/15/16
____________________________________________
Transaction date: 2026-03-03
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000592464
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 8930 Unit price: 2.5315 EUR
(2): Volume: 6723 Unit price: 2.5315 EUR
(3): Volume: 200 Unit price: 2.52 EUR
(4): Volume: 19 Unit price: 2.52 EUR
(5): Volume: 3 Unit price: 2.52 EUR
Aggregated transactions (5):
Volume: 15875 Volume weighted average price: 2.53134 EUR
LUOTEA PLC
More information:
Heikki Eskola, General Counsel, +358 50 586 5907
Luotea is a real estate service company that provides comprehensive solutions throughout the entire lifecycle of properties, integrating energy efficiency and data-driven technologies. Luotea’s services enhance property value and create the best possible conditions for property users. Our offering includes a wide range of advanced property maintenance, technical, and consulting services, as well as cleaning and support services.
Luotea operates in Finland and Sweden. In 2025, the company’s revenue totaled €346 million, and it employs approximately 5,000 people. Luotea is listed on Nasdaq Helsinki.
Distribution:
Nasdaq Helsinki
Media
www.luotea.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Cosmos Health Inc.24.8.2026 21:40:00 CEST | Press release
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Kitron ASA24.8.2026 17:07:52 CEST | Press release
Kitron revises full-year 2026 outlook upwards
Zealand Pharma24.8.2026 17:05:00 CEST | Press release
Zealand Pharma – Notification of holding of treasury shares
Zealand Pharma24.8.2026 17:00:00 CEST | Press release
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
Yacht Club de Monaco24.8.2026 16:57:59 CEST | Press release
Understand the superyacht world in nine weeks with La Belle Classe Academy and its Yachting Masterclass
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom